Novel Hematological Parameters in the Assessment of the Extent of Cardiac Implantable Electronic Device-Related Infections. Posted on January 9th, 2024 by LEADconnection Post navigation Previous: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.Next: The economic burden of cardiac implantable electronic device infections in Alberta, Canada: a population-based study using validated administrative data.
Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections. Posted on January 9th, 2024 by LEADconnection Post navigation Previous: Transvenous lead extraction safety and efficacy in infected and non-infected patients using mechanical-only tools, prospective registry from a high-volume center.Next: Novel Hematological Parameters in the Assessment of the Extent of Cardiac Implantable Electronic Device-Related Infections.
Transvenous lead extraction safety and efficacy in infected and non-infected patients using mechanical-only tools, prospective registry from a high-volume center. Posted on January 9th, 2024 by LEADconnection Post navigation Previous: Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT).Next: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.